| Variable | N | % |
| Histological types |
|
|
| WHO type III (UCNT) | 80 | 84.2 |
| WHO type I | 12 | 10.5 |
| WHO type II | 9 | 7.9 |
| LMNH | 4 | 3.5 |
| Stages |
|
|
| I | 2 | 1.8 |
| II | 33 | 28.9 |
| III | 42 | 36.8 |
| IVA | 25 | 21.9 |
| IVB | 12 | 10.5 |
| Treatment |
|
|
| Concomitant radiochemotherapy | 54 | 47.4 |
| Exclusive radiotherapy | 36 | 31.5 |
| Palliative chemotherapy | 13 | 11.4 |
| 1st chemotherapy + concomitant radiochemotherapy | 5 | 4.4 |
| 1st chemotherapy + Locking radiotherapy | 6 | 5.3 |